Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$709M |
| 2 |
Amazon
AMZN
|
+$653M |
| 3 |
Tesla
TSLA
|
+$457M |
| 4 |
Exxon Mobil
XOM
|
+$450M |
| 5 |
Uber
UBER
|
+$382M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$520M |
| 2 |
Netflix
NFLX
|
+$476M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$377M |
| 5 |
Apple
AAPL
|
+$374M |
Sector Composition
| 1 | Technology | 19.76% |
| 2 | Healthcare | 17.68% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Industrials | 7.95% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3076
GrowGeneration
GRWG
$92.6M
| $236K | ﹤0.01% |
+94,200
| New | +$236K |
|
|
KGEI
3077
Kolibri Global Energy
KGEI
$191M
| $236K | ﹤0.01% |
+61,250
| New | +$236K |
|
3078
Fidelity Total Bond ETF
FBND
$20.7B
| $235K | ﹤0.01% |
+5,100
| New | +$235K |
|
3079
SB Financial Group
SBFG
$136M
| $234K | ﹤0.01% |
+15,243
| New | +$234K |
|
3080
Solid Biosciences
SLDB
$413M
| $234K | ﹤0.01% |
38,071
+9,501
| +33% | +$58.4K |
|
3081
MVB Financial
MVBF
$305M
| $232K | ﹤0.01% |
10,300
+800
| +8% | +$18K |
|
3082
Neumora Therapeutics
NMRA
$264M
| $232K | ﹤0.01% |
+13,600
| New | +$232K |
|
|
AKYA
3083
DELISTED
Akoya BioSciences
AKYA
| $231K | ﹤0.01% |
47,400
-165,200
| -78% | -$805K |
|
3084
Cue Biopharma
CUE
$58.8M
| $230K | ﹤0.01% |
87,200
+27,400
| +46% | +$72.3K |
|
3085
Lyra Therapeutics
LYRA
$10.5M
| $230K | ﹤0.01% |
878
-118
| -12% | -$30.9K |
|
3086
Invesco WilderHill Clean Energy ETF
PBW
$365M
| $229K | ﹤0.01% |
+7,700
| New | +$229K |
|
|
CUTR
3087
DELISTED
Cutera, Inc.
CUTR
| $228K | ﹤0.01% |
64,793
-96,405
| -60% | -$339K |
|
3088
Lifecore Biomedical
LFCR
$291M
| $227K | ﹤0.01% |
36,700
-32,600
| -47% | -$202K |
|
3089
Xoma
XOMA
$442M
| $227K | ﹤0.01% |
12,296
-5,909
| -32% | -$109K |
|
3090
First Internet Bancorp
INBK
$209M
| $225K | ﹤0.01% |
9,319
-28,470
| -75% | -$687K |
|
|
TBHC
3091
The Brand House Collective, Inc. Common Stock
TBHC
$49.6M
| $225K | ﹤0.01% |
74,400
-21,800
| -23% | -$65.9K |
|
|
PET
3092
DELISTED
Wag!
PET
| $225K | ﹤0.01% |
128,186
+35,947
| +39% | +$63.1K |
|
|
BLTE
3093
Belite Bio
BLTE
$2.18B
| $224K | ﹤0.01% |
+4,900
| New | +$224K |
|
3094
Immix Biopharma
IMMX
$63.1M
| $224K | ﹤0.01% |
+32,400
| New | +$224K |
|
3095
FlexShopper
FPAY
$16.9M
| $223K | ﹤0.01% |
133,607
-18,517
| -12% | -$30.9K |
|
3096
PEDEVCO
PED
$55M
| $223K | ﹤0.01% |
289,103
-71,997
| -20% | -$55.5K |
|
3097
Direxion Daily FTSE China Bear 3X Shares
YANG
$160M
| $223K | ﹤0.01% |
+870
| New | +$223K |
|
3098
BGSF Inc
BGSF
$71.4M
| $222K | ﹤0.01% |
23,600
+2,300
| +11% | +$21.6K |
|
3099
CervoMed
CRVO
$82.8M
| $222K | ﹤0.01% |
29,033
-200
| -0.7% | -$1.53K |
|
3100
Dare Bioscience
DARE
$28.7M
| $222K | ﹤0.01% |
59,950
+4,050
| +7% | +$15K |
|